nach oben

International Urology and Nephrology

Erschienen in:

06.12.2022 | Nephrology - Original Paper

Association between the triglyceride–glucose index and chronic kidney disease in adults

verfasst von: Nuozhou Liu, Chang Liu, Zhan Qu, Jiaxing Tan

Erschienen in: International Urology and Nephrology | Ausgabe 5/2023

Einloggen, um Zugang zu erhalten

Abstract

Background

Chronic kidney disease (CKD) is characterized as a progressive dysfunction of the kidney, and it might have a close relationship with insulin resistance. We utilized the triglyceride–glucose (TyG) index, a reliable marker of insulin resistance, to evaluate the association between the TyG index and CKD in adults from the general population.

Methods

This was a cross-sectional study obtaining data from the 2015–2018 National Health and Nutrition Examination Survey. The estimated glomerular filtration rate (eGFR) and urinary albumin-to-creatinine ratio (UACR) served as kidney function indicators. We defined CKD as the existence of either low eGFR (eGFR < 60 mL/min/1.73 m² BSA) or albuminuria (UACR > 30 mg/g). Multivariate regressions, correlated subgroup analyses, and interaction terms were performed in this study.

Results

For 4361 recruited participants, the mean TyG index was 8.60 ± 0.68, and the prevalence of CKD was 13.35%. Participants with a higher TyG index showed a higher UACR level (β = 25.10, 95% CI: 6.76, 43.44, P = 0.0074) and higher levels of CKD (OR = 1.34, 95% CI: 1.13, 1.59, P = 0.0006). The positive relationship between the TyG index and CKD became stronger and remained significant in the overweight (OR = 1.61, 95% CI: 1.18, 2.20, P = 0.0027) and obese (OR = 2.48, 95% CI: 1.95, 3.15, P < 0.0001) groups and in people with diabetes (OR = 1.94, 95% CI: 1.46, 2.56, P < 0.0001).

Conclusions

Higher TyG index was strongly associated with a higher UACR level and higher values of albuminuria and CKD, which might be useful in kidney function screening especially among people in disadvantageous socioeconomic conditions with no availability for direct measurement of kidney function. However, more well-designed studies are still needed to validate this relationship.

Dikaiakou E, Vlachopapadopoulou EA, Paschou SA, Athanasouli F, Panagiotopoulos Ι, Kafetzi M, Fotinou A, Michalacos S (2020) Τriglycerides-glucose (TyG) index is a sensitive marker of insulin resistance in Greek children and adolescents. Endocrine 70:58–64. https://doi.org/10.1007/s12020-020-02374-6CrossRefPubMed

Bikbov B, Purcell CA, Levey AS, Smith M et al (2020) Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 395:709–733. https://doi.org/10.1016/s0140-6736(20)30045-3CrossRef

Levey AS, Andreoli SP, DuBose T, Provenzano R, Collins AJ (2007) Chronic kidney disease: common, harmful and treatable–World Kidney Day 2007. Am J Nephrol 27:108–112. https://doi.org/10.1159/000099801CrossRefPubMed

Levey AS, Andreoli SP, DuBose T, Provenzano R, Collins AJ (2007) Chronic kidney disease: common, harmful, and treatable–World Kidney Day 2007. J Am Soc Nephrol 18:374–378. https://doi.org/10.1681/asn.2006121305CrossRefPubMed

Smyth LJ, Duffy S, Maxwell AP, McKnight AJ (2014) Genetic and epigenetic factors influencing chronic kidney disease. Am J Physiol Renal Physiol 307:F757-776. https://doi.org/10.1152/ajprenal.00306.2014CrossRefPubMed

Neugut YD, Mohan S, Gharavi AG, Kiryluk K (2019) Cases in precision medicine: APOL1 and genetic testing in the evaluation of chronic kidney disease and potential transplant. Ann Intern Med 171:659–664. https://doi.org/10.7326/m19-1389CrossRefPubMedPubMedCentral

Genovese G, Friedman DJ, Ross MD, Lecordier L, Uzureau P, Freedman BI, Bowden DW, Langefeld CD, Oleksyk TK, Uscinski Knob AL et al (2010) Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 329:841–845. https://doi.org/10.1126/science.1193032CrossRefPubMedPubMedCentral

Orr SE, Bridges CC (2017) Chronic kidney disease and exposure to nephrotoxic metals. Int J Mol Sci. https://doi.org/10.3390/ijms18051039CrossRefPubMedPubMedCentral

Lebovitz HE (2001) Insulin resistance: definition and consequences. Exp Clin Endocrinol Diabetes 109(Suppl 2):S135-148. https://doi.org/10.1055/s-2001-18576CrossRefPubMed

10.

Navaneethan SD, Kirwan JP, Remer EM, Schneider E, Addeman B, Arrigain S, Horwitz E, Fink JC, Lash JP, McKenzie CA et al (2021) Adiposity, physical function, and their associations with insulin resistance, inflammation, and adipokines in CKD. Am J Kidney Dis 77:44–55. https://doi.org/10.1053/j.ajkd.2020.05.028CrossRefPubMed

11.

DeFronzo RA, Alvestrand A, Smith D, Hendler R, Hendler E, Wahren J (1981) Insulin resistance in uremia. J Clin Invest 67:563–568. https://doi.org/10.1172/jci110067CrossRefPubMedPubMedCentral

12.

Pham H, Utzschneider KM, de Boer IH (2011) Measurement of insulin resistance in chronic kidney disease. Curr Opin Nephrol Hypertens 20:640–646. https://doi.org/10.1097/MNH.0b013e32834b23c1CrossRefPubMedPubMedCentral

13.

Siew ED, Ikizler TA (2008) Determinants of insulin resistance and its effects on protein metabolism in patients with advanced chronic kidney disease. Contrib Nephrol 161:138–144. https://doi.org/10.1159/000130659CrossRefPubMed

14.

Shinohara K, Shoji T, Emoto M, Tahara H, Koyama H, Ishimura E, Miki T, Tabata T, Nishizawa Y (2002) Insulin resistance as an independent predictor of cardiovascular mortality in patients with end-stage renal disease. J Am Soc Nephrol 13:1894–1900. https://doi.org/10.1097/01.asn.0000019900.87535.43CrossRefPubMed

15.

Singh B, Saxena A (2010) Surrogate markers of insulin resistance: A review. World J Diabetes 1:36–47. https://doi.org/10.4239/wjd.v1.i2.36CrossRefPubMedPubMedCentral

16.

Simental-Mendía LE, Rodríguez-Morán M, Guerrero-Romero F (2008) The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord 6:299–304. https://doi.org/10.1089/met.2008.0034CrossRefPubMed

17.

Vasques AC, Novaes FS, de Oliveira Mda S, Souza JR, Yamanaka A, Pareja JC, Tambascia MA, Saad MJ, Geloneze B (2011) TyG index performs better than HOMA in a Brazilian population: a hyperglycemic clamp validated study. Diabetes Res Clin Pract 93:e98–e100. https://doi.org/10.1016/j.diabres.2011.05.030CrossRefPubMed

18.

Lee SH, Kwon HS, Park YM, Ha HS, Jeong SH, Yang HK, Lee JH, Yim HW, Kang MI, Lee WC et al (2014) Predicting the development of diabetes using the product of triglycerides and glucose: the Chungju Metabolic Disease Cohort (CMC) study. PLoS ONE 9:e90430. https://doi.org/10.1371/journal.pone.0090430CrossRefPubMedPubMedCentral

19.

Du T, Yuan G, Zhang M, Zhou X, Sun X, Yu X (2014) Clinical usefulness of lipid ratios, visceral adiposity indicators, and the triglycerides and glucose index as risk markers of insulin resistance. Cardiovasc Diabetol 13:146. https://doi.org/10.1186/s12933-014-0146-3CrossRefPubMedPubMedCentral

20.

Mirr M, Skrypnik D, Bogdański P, Owecki M (2021) Newly proposed insulin resistance indexes called TyG-NC and TyG-NHtR show efficacy in diagnosing the metabolic syndrome. J Endocrinol Invest 44:2831–2843. https://doi.org/10.1007/s40618-021-01608-2CrossRefPubMedPubMedCentral

21.

da Silva A, Caldas APS, Rocha D, Bressan J (2020) Triglyceride–glucose index predicts independently type 2 diabetes mellitus risk: A systematic review and meta-analysis of cohort studies. Prim Care Diabetes 14:584–593. https://doi.org/10.1016/j.pcd.2020.09.001CrossRefPubMed

22.

Tutunchi H, Naeini F, Mobasseri M, Ostadrahimi A (2021) Triglyceride glucose (TyG) index and the progression of liver fibrosis: A cross-sectional study. Clin Nutr ESPEN 44:483–487. https://doi.org/10.1016/j.clnesp.2021.04.025CrossRefPubMed

23.

Park K, Ahn CW, Lee SB, Kang S, Nam JS, Lee BK, Kim JH, Park JS (2019) Elevated TyG index predicts progression of coronary artery calcification. Diabetes Care 42:1569–1573. https://doi.org/10.2337/dc18-1920CrossRefPubMed

24.

Chen Y, Chang Z, Zhao Y, Liu Y, Fu J, Zhang Y, Liu Y, Fan Z (2021) Association between the triglyceride–glucose index and abdominal aortic calcification in adults: A cross-sectional study. Nutr Metab Cardiovasc Dis 31:2068–2076. https://doi.org/10.1016/j.numecd.2021.04.010CrossRefPubMed

25.

Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T et al (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604–612. https://doi.org/10.7326/0003-4819-150-9-200905050-00006CrossRefPubMedPubMedCentral

26.

Sanders AP, Mazzella MJ, Malin AJ, Hair GM, Busgang SA, Saland JM, Curtin P (2019) Combined exposure to lead, cadmium, mercury, and arsenic and kidney health in adolescents age 12–19 in NHANES 2009–2014. Environ Int 131:104993. https://doi.org/10.1016/j.envint.2019.104993CrossRefPubMedPubMedCentral

27.

Guo J, Wu C, Zhang J, Chang X, Zhang Y, Cao Y, Zhou Z (2020) Associations of melamine and cyanuric acid exposure with markers of kidney function in adults: Results from NHANES 2003–2004. Environ Int 141:105815. https://doi.org/10.1016/j.envint.2020.105815CrossRefPubMed

28.

Webster AC, Nagler EV, Morton RL, Masson P (2017) Chronic kidney disease. Lancet 389:1238–1252. https://doi.org/10.1016/s0140-6736(16)32064-5CrossRefPubMed

29.

Chapter 1: Definition and classification of CKD. Kidney Int Suppl (2011) 2013 3:19–62. doi:https://doi.org/10.1038/kisup.2012.64.

30.

Qin Z, Zhao J, Li J, Yang Q, Geng J, Liao R, Su B (2021) Low lean mass is associated with lower urinary tract symptoms in US men from the 2005–2006 national health and nutrition examination survey dataset. Aging (Albany NY) 13:21421–21434. https://doi.org/10.18632/aging.203480CrossRefPubMed

31.

Liu N, Ma F, Feng Y, Ma X (2021) The Association between the Dietary Inflammatory Index and Thyroid Function in U.S. Adult Males. Nutrients. https://doi.org/10.3390/nu13103330CrossRefPubMedPubMedCentral

32.

Wiener RC (2015) Serum cotinine and chronic pain NHANES 2003–2004. J Drug Abuse. https://doi.org/10.21767/2471-853X.10003CrossRefPubMedPubMedCentral

33.

Egan BM, Li J, Shatat IF, Fuller JM, Sinopoli A (2014) Closing the gap in hypertension control between younger and older adults: National Health and Nutrition Examination Survey (NHANES) 1988 to 2010. Circulation 129:2052–2061. https://doi.org/10.1161/circulationaha.113.007699CrossRefPubMedPubMedCentral

34.

Johnson CL, Paulose-Ram R, Ogden CL, Carroll MD, Kruszon-Moran D, Dohrmann SM, Curtin LR (2013) National health and nutrition examination survey: analytic guidelines, 1999–2010. Vital Health Stat 2:1–24

35.

Wang L, Cong HL, Zhang JX, Hu YC, Wei A, Zhang YY, Yang H, Ren LB, Qi W, Li WY et al (2020) Triglyceride–glucose index predicts adverse cardiovascular events in patients with diabetes and acute coronary syndrome. Cardiovasc Diabetol 19:80. https://doi.org/10.1186/s12933-020-01054-zCrossRefPubMedPubMedCentral

36.

Zhang K, Chen Y, Liu L, Lu M, Cheng J, Gao F, Wang N, Shen Z, Lu Y (2017) The Triglycerides and glucose index rather than HOMA-IR is more associated with Hypogonadism in Chinese men. Sci Rep 7:15874. https://doi.org/10.1038/s41598-017-16108-8CrossRefPubMedPubMedCentral

37.

Brito ADM, Hermsdorff HHM, Filgueiras MS, Suhett LG, Vieira-Ribeiro SA, Franceschini S, Novaes JF (2021) Predictive capacity of triglyceride–glucose (TyG) index for insulin resistance and cardiometabolic risk in children and adolescents: a systematic review. Crit Rev Food Sci Nutr 61:2783–2792. https://doi.org/10.1080/10408398.2020.1788501CrossRefPubMed

38.

Sánchez-García A, Rodríguez-Gutiérrez R, Mancillas-Adame L, González-Nava V, Díaz González-Colmenero A, Solis RC, Álvarez-Villalobos NA, González-González JG (2020) Diagnostic accuracy of the triglyceride and glucose index for insulin resistance: a systematic review. Int J Endocrinol 2020:4678526. https://doi.org/10.1155/2020/4678526CrossRefPubMedPubMedCentral

39.

Liu Y, Wu M, Xu J, Sha D, Xu B, Kang L (2020) Association between Triglyceride and glycose (TyG) index and subclinical myocardial injury. Nutr Metab Cardiovasc Dis 30:2072–2076. https://doi.org/10.1016/j.numecd.2020.06.019CrossRefPubMed

40.

Fritz J, Brozek W, Concin H, Nagel G, Kerschbaum J, Lhotta K, Ulmer H, Zitt E (2021) The triglyceride–glucose index and obesity-related risk of end-stage kidney disease in Austrian Adults. JAMA Netw Open 4:e212612. https://doi.org/10.1001/jamanetworkopen.2021.2612CrossRefPubMedPubMedCentral

41.

Lv L, Zhou Y, Chen X, Gong L, Wu J, Luo W, Shen Y, Han S, Hu J, Wang Y et al (2021) Relationship between the TyG index and diabetic kidney disease in patients with Type-2 diabetes mellitus. Diabetes Metab Syndr Obes 14:3299–3306. https://doi.org/10.2147/dmso.s318255CrossRefPubMedPubMedCentral

42.

Spoto B, Pisano A, Zoccali C (2016) Insulin resistance in chronic kidney disease: a systematic review. Am J Physiol Renal Physiol 311:F1087-f1108. https://doi.org/10.1152/ajprenal.00340.2016CrossRefPubMed

43.

Bergman RN, Ider YZ, Bowden CR, Cobelli C (1979) Quantitative estimation of insulin sensitivity. Am J Physiol 236:E667-677. https://doi.org/10.1152/ajpendo.1979.236.6.E667CrossRefPubMed

44.

Kawagishi T, Nishizawa Y, Konishi T, Kawasaki K, Emoto M, Shoji T, Tabata T, Inoue T, Morii H (1995) High-resolution B-mode ultrasonography in evaluation of atherosclerosis in uremia. Kidney Int 48:820–826. https://doi.org/10.1038/ki.1995.356CrossRefPubMed

45.

Qin Y, Tang H, Yan G, Wang D, Qiao Y, Luo E, Hou J, Tang C (2020) A High Triglyceride–glucose index is associated with contrast-induced acute kidney injury in Chinese patients with type 2 diabetes mellitus. Front Endocrinol (Lausanne) 11:522883. https://doi.org/10.3389/fendo.2020.522883CrossRefPubMed

46.

Thomas SS, Dong Y, Zhang L, Mitch WE (2013) Signal regulatory protein-α interacts with the insulin receptor contributing to muscle wasting in chronic kidney disease. Kidney Int 84:308–316. https://doi.org/10.1038/ki.2013.97CrossRefPubMedPubMedCentral

47.

Bailey JL, Zheng B, Hu Z, Price SR, Mitch WE (2006) Chronic kidney disease causes defects in signaling through the insulin receptor substrate/phosphatidylinositol 3-kinase/Akt pathway: implications for muscle atrophy. J Am Soc Nephrol 17:1388–1394. https://doi.org/10.1681/asn.2004100842CrossRefPubMed

48.

Kawazoe Y, Naka T, Fujimoto M, Kohzaki H, Morita Y, Narazaki M, Okumura K, Saitoh H, Nakagawa R, Uchiyama Y et al (2001) Signal transducer and activator of transcription (STAT)-induced STAT inhibitor 1 (SSI-1)/suppressor of cytokine signaling 1 (SOCS1) inhibits insulin signal transduction pathway through modulating insulin receptor substrate 1 (IRS-1) phosphorylation. J Exp Med 193:263–269. https://doi.org/10.1084/jem.193.2.263CrossRefPubMedPubMedCentral

49.

Okumura F, Matsuzaki M, Nakatsukasa K, Kamura T (2012) The role of elongin BC-containing ubiquitin ligases. Front Oncol 2:10. https://doi.org/10.3389/fonc.2012.00010CrossRefPubMedPubMedCentral

50.

Pereira BJ, Sundaram S, Snodgrass B, Hogan P, King AJ (1996) Plasma lipopolysaccharide binding protein and bactericidal/permeability increasing factor in CRF and HD patients. J Am Soc Nephrol 7:479–487. https://doi.org/10.1681/asn.v73479CrossRefPubMed

51.

Ndisang JF, Vannacci A, Rastogi S (2017) Insulin resistance, Type 1 and Type 2 diabetes, and related complications 2017. J Diabetes Res 2017:1478294. https://doi.org/10.1155/2017/1478294CrossRefPubMedPubMedCentral

52.

Gu S, Wang A, Ning G, Zhang L, Mu Y (2020) Insulin resistance is associated with urinary albumin-creatinine ratio in normal weight individuals with hypertension and diabetes: The REACTION study. J Diabetes 12:406–416. https://doi.org/10.1111/1753-0407.13010CrossRefPubMed

53.

Hill MA, Yang Y, Zhang L, Sun Z, Jia G, Parrish AR, Sowers JR (2021) Insulin resistance, cardiovascular stiffening and cardiovascular disease. Metabolism 119:154766. https://doi.org/10.1016/j.metabol.2021.154766CrossRefPubMed

Titel: Association between the triglyceride–glucose index and chronic kidney disease in adults
verfasst von: Nuozhou Liu
Chang Liu
Zhan Qu
Jiaxing Tan
Publikationsdatum: 06.12.2022
Verlag: Springer Netherlands
Erschienen in: International Urology and Nephrology / Ausgabe 5/2023
Print ISSN: 0301-1623
Elektronische ISSN: 1573-2584
DOI: https://doi.org/10.1007/s11255-022-03433-9

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Abstract

Background

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2023

Physical function and all-cause mortality in patients with chronic kidney disease and end-stage renal disease: a systematic review and meta-analysis

Economic evaluation of three dialysis methods in patients with end-stage renal disease in China

Salt taste threshold and contributory factors of chronic kidney disease patients: a cross-sectional study

Recent trends in the prescription of opioids in the emergency department in patients with urolithiasis

Preoperative endogenous total testosterone predicts prostate cancer progression: results in 580 consecutive patients treated with robot assisted radical prostatectomy for clinically localized disease